These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 18312164)
1. The role of tacrolimus in renal transplantation. Bowman LJ; Brennan DC Expert Opin Pharmacother; 2008 Mar; 9(4):635-43. PubMed ID: 18312164 [TBL] [Abstract][Full Text] [Related]
2. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149 [TBL] [Abstract][Full Text] [Related]
3. Tacrolimus in transplant rejection. Rath T Expert Opin Pharmacother; 2013 Jan; 14(1):115-22. PubMed ID: 23228138 [TBL] [Abstract][Full Text] [Related]
4. Tacrolimus Versus Cyclosporine as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation. Liu JY; You RX; Guo M; Zeng L; Zhou P; Zhu L; Xu G; Li J; Liu D Am J Ther; 2016; 23(3):e810-24. PubMed ID: 25299636 [TBL] [Abstract][Full Text] [Related]
5. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation. Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive drugs in paediatric liver transplantation. van Mourik ID; Kelly DA Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404 [TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitors in renal transplantation: what is the best option? Tanabe K Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261 [TBL] [Abstract][Full Text] [Related]
13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
14. Two Decades of Tacrolimus in Renal Transplant: Basic Science and Clinical Evidences. Shrestha BM Exp Clin Transplant; 2017 Feb; 15(1):1-9. PubMed ID: 27938316 [TBL] [Abstract][Full Text] [Related]
15. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625 [No Abstract] [Full Text] [Related]
16. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients. Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
18. Conversion from tacrolimus to neoral for postrenal transplant diabetes. Butani L; Makker SP Pediatr Nephrol; 2000 Dec; 15(3-4):176-8. PubMed ID: 11149106 [TBL] [Abstract][Full Text] [Related]
19. Trends in the use of immunosuppressive agents by outpatients after renal transplantation at a medical center in southern Taiwan. Mao PC; Lee EK; Tseng PL Transplant Proc; 2012 Jan; 44(1):185-9. PubMed ID: 22310611 [TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]